Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome

Fertil Steril. 2008 Nov;90(5 Suppl):S69-73. doi: 10.1016/j.fertnstert.2008.08.004.

Abstract

The role of insulin sensitizing agents is discussed at length in this Committee Opinion.

Publication types

  • Evaluation Study
  • Review

MeSH terms

  • Drug Resistance / drug effects*
  • Female
  • Glucose Tolerance Test
  • Health Planning Guidelines
  • Humans
  • Hyperinsulinism / complications
  • Hyperinsulinism / drug therapy*
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance* / physiology
  • Metformin / therapeutic use
  • Octreotide / therapeutic use
  • Ovulation Induction / methods
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / drug therapy*
  • Polycystic Ovary Syndrome / metabolism
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Metformin
  • Octreotide